Laura_Masurovsky
Laura P. Masurovsky
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413

Laura P. Masurovsky

Partner

  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
Laura_Masurovsky

Laura Masurovsky is an experienced litigator with more than 25 years of practice in federal and state courts. She concentrates on patent infringement and trade secret cases and strategic counseling for portfolio growth. With a focus on the biomedical industry, Laura is an active member of Finnegan's Israel practice.

Prior to joining Finnegan, Laura represented clients in commercial and white-collar criminal cases. She served as a special assistant U.S. attorney in the District of Columbia and as a legal advisor at the U.S. Department of State.

Laura previously served as a member of the firm's management committee, as head of the litigation section, and as leader of the IP specialties practice group. She has been recognized by Managing IP as an IP Star, and by The Legal 500 U.S. and Intellectual Asset Management for her patent litigation and licensing work. The Federal Circuit Bar Association presented Laura with a Committee Leadership Award (CLA) and a Committee Individual Leadership Award (CILA) for her contributions to the Amicus Committee.

Et Cetera

  • Federal Circuit Bar Association (president, 2021-present; president-elect, 2020-2021; treasurer, 2019-2020; secretary, 2018-2019; ABA house delegate, 2013-2015; co-chair, Amicus Committee, 2011-2013; co-chair, Litigation Committee, 2008-2011.)
  • Adjunct professor of patent law, Haifa University, 2010-2013; and Howard University School of Law, 2005-2009.
  • Adjunct professor of trial advocacy, George Washington University Law School, 2001-2005.

Experience

Eli Lilly and Company v. Genentech, Inc.
Successfully represented Lilly in post-grant review (PGR) proceeding relating to patent on IL-17A/F antibodies that had been asserted against Lilly’s blockbuster Taltz® pharmaceutical and in parallel district court litigation. Achieved institution of PGR, judgment in favor of petitioner, and dismissal of the district court case.

PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
Represented Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Won a jury verdict for Avid on issue of inventorship and patent ownership that was affirmed by the Federal Circuit, and obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The verdict disposed of a series of suits against numerous companies involved in scientific research relating to Alzheimer's disease.

2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager

Cumberland Pharmaceuticals Inc. v. Mylan Institutional, LLC
Counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and appeal.

16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer

Eli Lilly and Company v. Actavis Elizabeth LLC
Successfully represented Lilly in ANDA case on patent covering Strattera®, a treatment for ADHD. Prevailed on appeal at the Federal Circuit, holding patent not invalid and that defendants infringed.

10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk

Välinge Innovation AB v. Halstead New England Corporation, The Home Depot Inc. et al.
Represented global innovator of luxury vinyl tile and mechanical locking flooring in litigation to enforce a significant portfolio of patents. The case settled favorable shortly before trial.

1:16-cv-01082, D. Del., Judges Stark, Burke

Eli Lilly and Company v. Perrigo Co.

Co-lead counsel for plaintiffs in consolidated ANDA cases involving Axiron®.

1:13-cv-00851, S.D. Ind., Judges Barker, Dinsmore, LaRue

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

Represented Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Won a jury verdict for Avid on issue of inventorship and patent ownership that was affirmed by the Federal Circuit, and obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The verdict disposed of a series of suits against numerous companies involved in scientific research relating to Alzheimer's disease.

2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

Represented Biogen in a Hatch-Waxman litigation involving twenty-eight companies seeking FDA approval to market generic versions of Tecfidera®.

1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley

Cumberland Pharmaceuticals Inc. v. Mylan Institutional, LLC

Lead counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and on appeal.

16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer

Eli Lilly and Company v. Genentech, Inc.

Successfully represented Lilly in post-grant review (PGR) proceeding relating to patent on IL-17A/F antibodies that had been asserted against Lilly’s blockbuster Taltz® pharmaceutical and in parallel district court litigation. Achieved institution of PGR, judgment in favor of petitioner, and dismissal of the district court case.

PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Successfully represented Eli Lilly and Company in Hatch-Waxman patent litigation relating to osteoporosis drug Forteo®.

1:16-cv-00596, S.D. Ind., Judges Pratt, Brookman

Välinge Innovation AB v. Halstead New England Corporation, The Home Depot Inc. et al.

Represented global innovator of luxury vinyl tile and mechanical locking flooring in litigation to enforce a significant portfolio of patents. The case settled favorable shortly before trial.

1:16-cv-01082, D. Del., Judges Stark, Burke

More

Insights

Event

Global Updates in Patent Law - A Closer Look at Ensuring Patent Longevity During Prosecution and in Post-Grant Proceedings: Part I Global Updates in Patent Law - A Closer Look at Ensuring Patent Longevity During Prosecution and in Post-Grant Proceedings: Part I

January 25, 2023

Webinar

Event

9th Best Practices in Intellectual Property Master Class

9th Best Practices in Intellectual Property Master Class

November 14, 2022

Raanana

Event

2022 Bench & Bar Conference 2022 Bench & Bar Conference

June 15-18, 2022

Sea Island

Articles

Innovation Reboot

Innovation Reboot Innovation Reboot

May 10, 2022

Haaretz Biomed Magazine

Event

2021 Bench & Bar Virtual Conference 2021 Bench & Bar Virtual Conference

June 21-25, 2021

Virtual

Conference

FCBA Global Series Fall 2020 FCBA Global Series Fall 2020

September 25 - December 15, 2020

Virtual

More

Upcoming Events

Event

Global Updates in Patent Law - A Closer Look at Ensuring Patent Longevity During Prosecution and in Post-Grant Proceedings: Part II Global Updates in Patent Law - A Closer Look at Ensuring Patent Longevity During Prosecution and in Post-Grant Proceedings: Part II

February 22, 2023

Webinar

News

Press Release

Finnegan Secures a Jury Win for Under Armour in Trademark Suit Finnegan Secures a Jury Win for Under Armour in Trademark Suit

January 24, 2023

Commentary

Litigator of the Week: Standing Strong for Under Armour’s Trademarks Without Going Overboard Against Upstart Armorina Litigator of the Week: Standing Strong for Under Armour’s Trademarks Without Going Overboard Against Upstart Armorina

January 20, 2023

The AmLaw Litigation Daily

Commentary

Under Armour Wins in TM Suit Against Armorina Under Armour Wins in TM Suit Against Armorina

January 13, 2023

Law360

Commentary

How I Made It to Law Firm Leadership: 'Have a Steadfast Commitment to Promoting an Objective and Inclusive Dialogue,' Says Laura Masurovsky of Finnegan How I Made It to Law Firm Leadership: 'Have a Steadfast Commitment to Promoting an Objective and Inclusive Dialogue,' Says Laura Masurovsky of Finnegan

June 22, 2022

Law.com

Announcement

More than 30 Finnegan Attorneys Named to IP Stars List by Managing IP More than 30 Finnegan Attorneys Named to IP Stars List by Managing IP

June 1, 2022

Managing Intellectual Property

Commentary

Vidal Looks All Set to Lead the USPTO After Confident Senate Hearing Vidal Looks All Set to Lead the USPTO After Confident Senate Hearing

December 2, 2021

Intellectual Asset Management
More

Professional Activities

  • Federal Circuit Bar Association
    (president, 2021-present; president-elect, 2020-2021; treasurer, 2019-2020; secretary, 2018-2019; ABA house delegate, 2013-2015; co-chair, Amicus Committee, 2011-2013; co-chair, Litigation Committee, 2008-2011)
  • American Intellectual Property Law Association
  • Women's Bar Association
  • American Bar Association
Admissions and Education

Admissions

  • District of Columbia
  • Maryland
  • New York
  • Virginia
  • U.S. Court of Appeals, Federal Circuit
  • Supreme Court of the United States

Education

Harvard Law School
J.D., cum laude, 1983
Tufts University
B.A., French/Russian, summa cum laude, 1977

Languages

  • French
  • Russian

Laura's Practices

Patent Litigation
Appeals
Branded Hatch-Waxman (ANDA)
Patent Trial
Pre-Trial Strategy
Settlement
Patent Portfolio Management, Monetization, and Transactions
Antitrust and Misuse
Licensing, Pooling, and Other Transactions
Trade Secrets

Laura's Industries

Electronics and Information Technology
Electrical and Computer Technology
Life Sciences
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

The Finnegan UPC Hub is a one-stop shop for our insights related to the Unified Patent Court (UPC).

Click Here